Skip to main navigation Skip to search Skip to main content

Rifaximin-a reduces circulating ceramides and increases phosphatidylcholines in patients with ALD: A lipidome analysis of the GALA-RIF trial

  • Steno Diabetes Center Copenhagen
  • Münster University Hospital
  • Nordic Bioscience
  • University of Copenhagen
  • European Molecular Biology Laboratory
  • European Foundation for the Study of Chronic Liver Failure

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalHepatology
Volume78
Issue numberSupp. 1
Pages (from-to)1645-1646
ISSN0270-9139
Publication statusPublished - 10. Oct 2023
EventThe Liver Meeting - Boston, United States
Duration: 10. Nov 202314. Nov 2023

Conference

ConferenceThe Liver Meeting
Country/TerritoryUnited States
CityBoston
Period10/11/202314/11/2023

Cite this